Tumor markers are most effective when used in conjunction with other diagnostic tools and clinical evaluations. In CAR T-cell therapy, tumor markers are crucial for identifying specific cancer cell antigens that the engineered T cells can target.
By recognizing these markers, CAR T-cells are tailored to attack cancer cells with precision, improving treatment efficacy and reducing damage to healthy tissues. Additionally, tumor markers help monitor the effectiveness of the therapy by tracking changes in marker levels, assess the tumor burden, and guide treatment adjustments, ensuring a more personalized and responsive approach to cancer treatment.
Tumor markers are essential in selecting patients for CAR T-cell therapy as they help identify the presence and level of specific antigens on cancer cells that CAR T-cells are designed to target. By evaluating these markers, clinicians can determine whether a patient’s cancer cells express the target antigen at sufficient levels for effective treatment, classify the disease, and assess the tumor burden. This information ensures that CAR T-cell therapy is tailored to those most likely to benefit, optimizing treatment efficacy and avoiding unnecessary interventions for patients whose cancer does not match the therapy’s target.
Tumor markers are instrumental in monitoring disease progression and response to CAR T-cell therapy by providing measurable indicators of cancer activity and treatment effectiveness. After CAR T-cell therapy, regular testing of tumor markers helps assess the reduction or persistence of the target antigen on tumor cells, indicating whether the therapy is successfully eliminating the cancer. A decrease in specific tumor markers typically suggests that the CAR T-cells are effectively targeting and destroying cancer cells. Conversely, an increase in these markers may signal residual disease or relapse. Monitoring these markers also helps track side effects related to the therapy and allows for timely intervention if adverse effects or complications arise. Overall, tumor markers provide critical insights into how well the therapy is working and guide subsequent treatment decisions.
